Abiopharma

(99% Neutral) IRIDEX CORPORATION (IRIX) Announces Business Combination

Campbell Elizabeth S 🟡 adjusted position in 5.8K shares (1 derivative) of Cencora, Inc. (COR) at $350.30 ($2.0M) Transaction Date: Mar 11, 2026 | Filing ID: 000004

Director FOLETTA MARK G 🟢 acquired 20.0K shares (1 derivative) of ENANTA PHARMACEUTICALS INC (ENTA) at $14.17 Transaction Date: Mar 11, 2026 | Filing ID: 000139

(10% Negative) PROGYNY, INC. (PGNY) Files Form 8-K

Director Singer Michael 🔴 sold 6.6K shares of Cartesian Therapeutics, Inc. (RNAC) Transaction Date: Mar 13, 2026 | Filing ID: 000066

Director CARTER BRUCE L A 🟢 acquired 20.0K shares (1 derivative) of ENANTA PHARMACEUTICALS INC (ENTA) at $14.17 Transaction Date: Mar 11, 2026 | Filing ID: 000138

Cleary James F 🟡 adjusted position in 5.4K shares (1 derivative) of Cencora, Inc. (COR) at $350.30 ($1.9M) Transaction Date: Mar 11, 2026 | Filing ID: 000002

McKechnie Duncan 🔴 sold 2.6K shares of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $498.42 ($1.3M) Transaction Date: Mar 11, 2026 | Filing ID: 000138

Director SUSSMAN ELLIOT J MD MBA 🟡 adjusted position in 2.5K shares (2 derivative) of UNIVERSAL HEALTH SERVICES INC (UHS) at $194.27 ($1.2M) Transaction Date: Mar 11, 2026 | Filing ID: 000004

Director MAETZOLD DEREK J 🟡 adjusted position in 44.1K shares (1 derivative) of CASTLE BIOSCIENCES INC (CSTL) at $26.11 ($1.2M) Transaction Date: Mar 11, 2026 | Filing ID: 017694